Condition
COPD Asthma
ClinicalTrials.gov condition label
How to interpret these research links
Connected source recordsThis is the original ClinicalTrials.gov condition label, found in 15 distinct published trials. It is kept separate from a MONDO disease identifier until a specific normalization is supported. Related interventions are co-recorded in studies; they are not medical recommendations.
Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.
Advertisement
Clinical trials
15 shownCytisine vs Nicotine Replacement TherapyNCT03249428 · 2025-11-04
ENROLLING_BY_INVITATIONUsing Artificial Intelligence for the Detection of Respiratory Diseases Associated With PollutionNCT06512142 · 2023-11-01
UNKNOWNORCHARD- Optimising Home Assessment of Rural PatientsNCT05732922 · 2023-02-01
COMPLETEDHome Spirometry in Primary Care: an Implementation StudyNCT05162157 · 2021-09-27
COMPLETEDThe Effect of Progressive Relaxation and Breathing Exercise on Sleep Quality and Exercise Self-Efficacy in Patients With COPDNCT05397275 · 2021-02-01
COMPLETEDPulmonary Specialist-Health Coach Consult Model StudyNCT03695276 · 2020-10-20
COMPLETEDPhenotype Assessment of Blood and Airway Eosinophils in Patients With COPD and AsthmaNCT05398133 · 2020-09-01
UNKNOWNDevelopment and Evaluation of Clinical Pharmacy Services in Respiratory DiseasesNCT05564156 · 2020-06-30
COMPLETEDThe Effect of Long Term Therapy With High Flow Humidification Compared to Usual Care in Patients With Bronchiectasis (BX)NCT04142827 · 2019-09-04
UNKNOWNThe Role of Gas Flow in Transnasal Pulmonary Aerosol Delivery: A Double-blinded, Randomized Controlled TrialNCT03739359 · 2019-02-01
COMPLETEDEvaluation of the Right Use of Inhaled TherapeuticsNCT03395418 · 2017-12-01
COMPLETEDAccuracy of Spircare Device as Compared to the Conventional PlethysmographNCT03056066 · 2017-07-31
UNKNOWNReducing Diagnostic Error to Improve Patient Safety in COPD and Asthma (REDEFINE Study)NCT03137303 · 2017-07-01
COMPLETEDEvaluation of Inhalation Technique in Patients With COPD, Asthma or ACOS Using a Dry Powder Device (DPI)NCT03275935 · 2017-03-01
COMPLETEDIdentifying Patients With the COPD-Asthma Overlap Phenotype: Therapeutic ImplicationsNCT02985814 · 2015-02-04
COMPLETEDCommon interventions
A sphygmanometer, a digital thermometer, a pulse oximeter and a peak flow meter will be given to participants to use during their telemedicine consultations with health care providers.DEVICE1AlbuterolDRUG1breathe exercisesOTHER1CytisineDRUG1High Flow HumidificationDEVICE1Intervention groupsBEHAVIORAL1nasal cannula gas flowOTHER1Nicotine replacement therapy (NRT)DRUG1NuvoAir platformDEVICE1PlethysmographDEVICE1progressive muscle relaxation+breathe exercisesOTHER1PushCon ModelBEHAVIORAL1Spirometry at 12-month follow-upDEVICE1Spirometry at initial visitDEVICE1Usual careBEHAVIORAL1
Mapped drugs appearing in these trials
Shared trial participation only; not evidence of efficacy or approval.
Leading sponsors
Association Nationale pour les Traitements A Domicile, les Innovations et la Recherche
1
Bezmialem Vakif University
1
Clalit Health Services
1
Dr. Giuseppe Fiorentino
1
General Practitioners Research Institute
1
Kathmandu University School of Medical Sciences
1
Medical University of Warsaw
1
Osmaniye Korkut Ata University
1
Ottawa Hospital Research Institute
1
Rush University Medical Center
1
Spircare Ltd.
1
University of Aberdeen
1
University of California, San Francisco
1
University of Illinois at Chicago
1
University of Medicine and Pharmacy "Victor Babes" Timisoara
1
Trial status mix
COMPLETED10
UNKNOWN4
ENROLLING_BY_INVITATION1
Phase mix
NA7
PHASE31
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.